Sylk ai publishes algorithmically generated market commentary for informational and educational purposes only. Nothing on this site is investment advice, a recommendation, or an offer or solicitation to buy or sell any security. Content is generated by AI models analyzing public news and is not tailored to any individual's financial situation. sylk.ai is not a registered investment adviser or broker-dealer, and no advisory or fiduciary relationship is created by your use of this site. Predictions are probabilistic estimates, not guarantees — past accuracy does not predict future results. Do your own research and consult a licensed financial professional before making any investment decision. Full disclaimer →
markets closed
JNJ
Johnson & Johnson Q3 Sets 'Negative Tone For Broader Pharma Sector': Analystsclosest▲+0.4%
expired▲+1.3%
WFC
Wells Fargo Analysts Lower Their Forecasts After Q3 Resultsclosest▼-0.4%
expired▼-2.8%
UNH
UnitedHealth Analysts Slash Their Forecasts Following Q3 Resultsclosest▼-0.3%
expired▼-2.0%
JPM
JPMorgan Chase Q2 Results Were ‘Best-In-Class,’ Analyst Highlights CIB As Standout Segmentclosest▼-0.2%
expired▼-1.0%
QCOM
Gemtek, Qualcomm und gFiber arbeiten zusammen, um Edge-KI in Wi-Fi 8 Breitbandgateways zu integrierenclosest▲+0.7%
expired▲+1.0%
BAC
Bank of America Hit with $1.2 Billion Treasury Penalties on Eve of Earningshigh confidence·resolves in 17h·closest▼-0.7%
predicts▼-2.0%
JPM
JPMorgan Sees Deal Delays, Not Cancellations, During Market Uncertaintyclosest▲+0.4%
expired▲+1.2%
QCOM
Qualcomm Statement on Trial Verdict Winclosest▲+0.8%
expired▲+4.6%
UNH
UnitedHealth Stock Wobbles Despite 61% Profit Jump, Boosted Outlookclosest▲+0.1%
expired▲+1.8%
JNJ
TREMFYA® (guselkumab) demonstrated sustained clinical and endoscopic remission through 3 years in moderately to severely active Crohn's diseaseclosest▲+0.3%
expired▲+0.9%
PFE
Pfizer Expands Breast Cancer Drug Reach with New FDA Nod for Metastatic Diseaseclosest▲+0.0%
expired▲+1.0%
WFC
'Wells Fargo Faces Regulator Probe Over Efforts to Boost Black Homeownership' - WSJ Exclusiveclosest▼-0.2%
expired▼-1.0%
MU
Reported Earlier, 'Micron Tech chipmaker union in Taiwan gets OK to strike' - Reuters✓ hit target in 3h 20m·called -1.5%
confirmed▼-1.9%
UNH
Texas AG Targets UnitedHealth: Probe Examines Alleged Bribes, Care Delays and Coverage Denialsclosest▼-0.2%
expired▼-1.5%
AVGO
Challenging Nvidia's Dominance: Broadcom Pairs Custom TPU Chips with $60 Billion Debt Packageclosest▲+0.4%
expired▲+2.2%
INTC
Applied Materials, Intel Partnering Over Development Of Chipmaking Innovations For Transistors, Interconnects, Packing Technologies✓ hit target in 50m·called +0.7%
confirmed▲+1.1%
MU
Netlist, Micron Agrees To Resolve Previous Pending Legal Proceedings; Micron To Pay $30M Per Quarter to Netlist From Q4 2026 Through Q3 2031closest▼-0.1%
expired▼-1.0%
TSLA
TSLA Stock May Have 'More Near-Term Upside' as Delivery Beat Changes the Math — Gary Black Sees 'Room' Beyond Recent $23-Per-Share Gainclosest▲+0.0%
expired▲+1.5%
KO
Wells Fargo Maintains Overweight on Coca-Cola, Lowers Price Target to $90closest▼-0.2%
expired▼-0.8%
IBIT
Strategy Buys 334 Bitcoin but Strive Bought 2,000: What's Going On?closest▲+0.2%
expired▲+2.0%
TSLA
Elon Musk's Tesla Delivered More Cars Than Wall Street Expected — So Why Is This Top Analyst Still Wary of TSLA Stock?closest▲+0.8%
expired▲+1.1%
AMZN
Amazon Reportedly Seeks to Move $8 Billion of Nvidia Chips Off Its Balance Sheetclosest▲+0.4%
expired▲+0.6%
UNH
UnitedHealthcare, Aetna Tighten Medicare Advantage Networks as 2027 Costs Rise: ‘We Can’t Ignore the Realities…’✓ hit target in 50m·called -0.8%
confirmed▼-1.2%
TSLA
This Week in TSLA: Elon Musk Trims Optimus Memory, Roadster Delays And More✓ hit target in 20m·called +1.0%
confirmed▲+1.2%
HON
INVESTOR NOTICE: Honeywell Aerospace Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit before November 23, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - HONAclosest▲+0.0%
expired▼-1.2%
UNH
Unitedhealthcare 2027 Introduces Medicare Plans, Including Access To $0 Premium Plans, $0 Primary Care Visits And Affordable Prescription Drug Coverage✓ hit target in 55m·called +0.7%
confirmed▲+0.7%
AVGO
Broadcom To Lend Up To $42 Billion To Anthropic For Infrastructure Lease Agreements, According To IPO Prospectus✓ hit target in 10m·called +1.0%
confirmed▲+1.1%
MU
Micron Stock Has Made Historic Run, Traders Are Now Asking What’s Leftclosest▲+0.0%
expired▲+1.5%
PFE
Pfizer Advances Tilrekimig Into Phase 3 Atopic Dermatitis And Asthma Trials After Phase 2 Study Showed Statistically Significant EASI-75 Gains At Week 16 And No Dose-Dependent Safety Signalsclosest▲+0.2%
expired▲+1.0%
TSLA
Tesla Announces Approval Of FSD Supervised In Croatia, Says Rollout Will Begin Soonclosest▲+0.8%
expired▲+1.0%

AI-generated estimate, not investment advice or a recommendation — for informational purposes only. No guarantee of accuracy; do your own research.